Lymphoma Podcasts Lymphoma RSS feedThis is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

Biomarkers in lymphoma
In this interview with Arjan Diepstra, PhD, from the University of Groningen, Groningen, Netherlands, speaking from the 23rd congress of the European Haematology Association (EHA) 2018, held in Stockh... Author: VJHemOnc Added: 07/23/2018 (Source: Oncology Tube)
Source: Oncology Tube - July 23, 2018 Category: Cancer & Oncology Source Type: podcasts

Immunotherapy in common solid tumors: an overview
Much of the focus for immunotherapy research is on the cancers for which it works best, such as Hodgkin lymphoma and lung cancer. Elaine Vickers, BMedSc, PhD, from Science Communicated Ltd, Manchester... Author: VJOncology Added: 07/18/2018 (Source: Oncology Tube)
Source: Oncology Tube - July 18, 2018 Category: Cancer & Oncology Source Type: podcasts

Preventing early disease progression in follicular lymphoma
While treatment for follicular lymphoma (FL) has improved in recent years, allowing most patients to have good outcomes, there remains a small subset of patients who experience disease progression wit... Author: VJHemOnc Added: 07/18/2018 (Source: Oncology Tube)
Source: Oncology Tube - July 18, 2018 Category: Cancer & Oncology Source Type: podcasts

Identifying predictive factors of outcome in elderly lymphoma
In this video, Raul Cordoba, MD, PhD, outlines the pre-clinical studies that are occurring at the Fundacion Jimenez Diaz University Hospital, Madrid, Spain, including baseline analysis of patients im... Author: VJHemOnc Added: 07/18/2018 (Source: Oncology Tube)
Source: Oncology Tube - July 18, 2018 Category: Cancer & Oncology Source Type: podcasts

Updates from the COSMOS trial: MOR208 for the treatment in R/R CLL
MOR208 is an anti-CD19 monoclonal antibody that has been effective in treating a range of lymphomas, including diffuse large B-cell lymphoma. Here, Wojciech Jurczak, MD, PhD, from Jagiellonian Univers... Author: VJHemOnc Added: 07/18/2018 (Source: Oncology Tube)
Source: Oncology Tube - July 18, 2018 Category: Cancer & Oncology Source Type: podcasts

Geriatric oncology: immunotherapy for elderly patients with lymphoma
The European Hematology Association (EHA) Scientific Working Group on Aging and Hematology released a new edition about geriatric oncology. Here, Raul Cordoba, MD, PhD, from the Fundacion Jimenez Diaz... Author: VJHemOnc Added: 07/18/2018 (Source: Oncology Tube)
Source: Oncology Tube - July 18, 2018 Category: Cancer & Oncology Source Type: podcasts

Future improvements in developing CLL therapy
While the treatment landscape of chronic lymphocytic lymphoma (CLL) has been exciting with many breakthrough therapies, there are still key areas for improvement. Speaking from the British Society for... Author: VJHemOnc Added: 07/13/2018 (Source: Oncology Tube)
Source: Oncology Tube - July 13, 2018 Category: Cancer & Oncology Source Type: podcasts

Checkmate 205 study results: nivolumab in classical Hodgkin Lymphoma
The Checkmate 205 study (NCT02181738) is looking at nivolumab in previously treated and newly diagnosed patients with classical Hodgkin lymphoma. Here, Graham Collins, MA, MBBS, MRCP, FRCPath, DPhil, ... Author: VJHemOnc Added: 07/12/2018 (Source: Oncology Tube)
Source: Oncology Tube - July 12, 2018 Category: Cancer & Oncology Source Type: podcasts

Challenges within follicular lymphoma treatment
Difficult multidisciplinary team decisions occur within follicular lymphoma (FL) due to the heterogeneity that exists within the disease. In this video, Wendy Osborne, MBBS (Hons), MRCP, FRCPath, of N... Author: VJHemOnc Added: 07/12/2018 (Source: Oncology Tube)
Source: Oncology Tube - July 12, 2018 Category: Cancer & Oncology Source Type: podcasts

Polatuzumab vedotin and CAR T-cell therapy for diffuse large B-cell lymphoma
There have been many promising therapies for lymphoma recently, with several interesting clinical trials in progress or upcoming. In this video, Graham Collins, MA, MBBS, MRCP, FRCPath, DPhil, from Ox... Author: VJHemOnc Added: 07/12/2018 (Source: Oncology Tube)
Source: Oncology Tube - July 12, 2018 Category: Cancer & Oncology Source Type: podcasts

BSH 2018: updates in lymphoma research
Wendy Osborne, MBBS (Hons), MRCP, FRCPath, of Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle, UK, gives an overview of the talks given regarding recent updates in lymphoma research at t... Author: VJHemOnc Added: 07/12/2018 (Source: Oncology Tube)
Source: Oncology Tube - July 12, 2018 Category: Cancer & Oncology Source Type: podcasts

Accelerating patient outcomes in lymphoma
While there has been a range of new therapeutic options emerging for lymphoma, this introduces the challenge of assessing them quickly yet thoroughly. However, a consequence of rapid development is th... Author: VJHemOnc Added: 07/12/2018 (Source: Oncology Tube)
Source: Oncology Tube - July 12, 2018 Category: Cancer & Oncology Source Type: podcasts

John P. Leonard, MD - The Arrival of Novel Agent Classes in B-Cell Non-Hodgkin Lymphoma: A Personal Guide to Integrating New Therapy Into Patient Care
The Arrival of Novel Agent Classes in B-Cell Non-Hodgkin Lymphoma: A Personal Guide to Integrating New Therapy Into Patient Care (Source: PeerView CME/CE Audio Podcast - Pulmonology)
Source: PeerView CME/CE Audio Podcast - Pulmonology - July 9, 2018 Category: Respiratory Medicine Authors: PVI, PeerView Institute for Medical Education Tags: Science, Medicine Source Type: podcasts

Hodgkin lymphoma: when autologous transplant is unsuccessful
Autologous transplant is unsuccessful in ~50% of Hodgkin lymphoma (HL) patients. Here, Stephen Robinson, MBBS, MRCP, MRCPath, PhD, of University Hospitals Bristol NHS Foundation Trust, Bristol, UK, de... Author: VJHemOnc Added: 07/06/2018 (Source: Oncology Tube)
Source: Oncology Tube - July 6, 2018 Category: Cancer & Oncology Source Type: podcasts

Primary CNS lyphoma: can we use MATRix immunochemo in the real world?
MATRix immunochemotherapy induction therapy has produced promising results in the recent IELSG32 trial (NCT01011920) for primary CNS lymphoma (PCNSL). However, here at the British Society for Haematol... Author: VJHemOnc Added: 06/27/2018 (Source: Oncology Tube)
Source: Oncology Tube - June 27, 2018 Category: Cancer & Oncology Source Type: podcasts